Issues In Homeopathic Research And Advanced Homeopathy | 18901
Alternative & Integrative Medicine
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
India has the largest number of practitioners of homeopathy and a very large consumer base for it. Globally,
homeopathic research has been directed towards understanding the therapeutic effects of pre-existing drugs in the context of
well defined clinical entities. New applications are being discovered for drugs that are already available.
The generation of high quality evidence like randomised controlled trials, outcome assessment and pooling of data in the
form of systematic reviews is a cost intensive activity.
There are very few institutions and practitioners with resources or interest in homeopathic research due to
absence of incentives and a low impact on practice. Advanced Homeopathy was developed by Prof. Parimal Banerji. The
origins of the protocol are in 1918. Advanced Homeopathy is based on observational studies of case records, spread over ninety
one years of practice of homeopathy in the same family, across four generations and a patient base of approximately 18 million
cases. However, this research has very little protection from intellectual property laws in their current form.
Generating evidence to understand the use of prevalent homeopathic drugs in modern disease should be a pre requisite
for any system of medicine to be adopted by a health delivery service.
Therapeutic regimens like Advanced Homeopathy are able to provide quick, reliable prescription with replicable
results. A large number of difficult illnesses are being addressed by practitioners trained in Advanced Homeopathy. As health
delivery systems evolve and there is an increase in insurance coverage in countries like India, only those alternative systems
with a good evidence base will be practiced for the masses. Structured therapeutic regimens are required to build a good
Due to limited protection of intellectual property and a low return on investment for research this base is weak and there
is a risk of the homeopathic system being withdrawn from the health services in India in the coming years.
Kushal Banerjee is a MD in Homeopathy and has MSc in Evidence Based Health Care from the University of Oxford. He has received training at the Harvard Medical School in several areas of clinical medicine. He practices at Dr. Kalyan Banerjees Clinic, New Delhi, prescribing for over a hundred and fifty patients a day. He is the fourth generation of homeopaths in his family. He has a special interest in creating a good evidence base in homeopathy for drug regimens used to treat difficult clinical conditions at the Clinic, using clinical data spanning over ninety years in the family practice.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals